Stay updated with breaking news from Hazard Ratio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes.
An unprecedented 60% of patients remain alive without disease progression after five years Updated results show continued 81% reduction in risk of progression or death and 94% reduction in...
An analysis of more than 800 IgAN patients treated from 2002-2021 provides an overview of factors associated with anemia as well as its impact on prognosis.
Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.
1. In this retrospective study, the chest X-ray cardiovascular disease (CXR CVD)-risk model performed similarly to the standard atherosclerotic (AS) CVD risk score at predicting 10-year risk for major adverse cardiovascular events (MACE). 2. Among patients with an unknown ASCVD risk score, those deemed statin-eligible by the model were nearly twice as likely to have